IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Mark F McCarty

USPTO Granted Patents = 15 

Average Co-Inventor Count = 1.2

ph-index = 14

Forward Citations = 298(Granted Patents)


Company Filing History:

goldMedal13 out of 37 
 
Nutrition 21, Inc.
 patents
silverMedal1 out of 29 
 
Ambi Inc.
 patents
bronzeMedal1 out of 1 
 
Pcb Associates, Inc.
 patent

Years Active: 1996-2014

Loading Chart...
15 patents (USPTO):Explore Patents
1. 8709434 - Compositions for inhibiting NADPH oxidase activity (2014-04-29),
2. RE39480 - Chromium/biotin treatment of type II diabetes (2007-01-22),
3. 6344444 - Arginine-silicate-inositol complex and use thereof (2002-02-05),
4. 6329361 - High-dose chromic picolinate treatment of type II diabetes (2001-12-11),
5. 6203823 - Calcium taurate as a dietary supplement (2001-03-20),
6. 6156735 - Arginine silicate inositol complex and use thereof (2000-12-05),
7. 6099869 - Calcium taurate and antihypertensive drug for hypertension (2000-08-08),
8. 5929066 - Chromium/biotin treatment of Type II diabetes (1999-07-27),
9. 5914326 - Method for promoting weight and fat loss (1999-06-22),
10. 5876757 - Pharmaceutical composition for rapid thrombolytic therapy (1999-03-02),
11. 5789401 - High-dose chromium/biotin treatment of type II diabetes (1998-08-04),
12. 5776504 - Magnesium taurate for prevention and treatment of pre-eclampsia/eclampsia (1998-07-07),
13. 5776498 - Magnesium taurate as an adjuvant to rapid thrombolytic therapy (1998-07-07),
14. 5707970 - Arginine silicate complex and use thereof (1998-01-13),
15. 5582839 - Magnesium taurate and other mineral taurates (1996-12-10),

Title: The Innovative Mind of Mark F McCarty

Introduction:

Mark F McCarty, a prolific inventor based in San Diego, CA, has made significant contributions to the field of healthcare with his groundbreaking patents. With 15 patents to his name, McCarty continues to push the boundaries of innovation in medicine and beyond.

Latest Patents:

McCarty's recent patents include "Compositions for inhibiting NADPH oxidase activity" and "Chromium/biotin treatment of type II diabetes". The former highlights the use of phycobilins as inhibitors of NADPH oxidase activity for medical conditions, while the latter focuses on a novel method for treating Type II diabetes using a combination of chromic tripicolinate and biotin.

Career Highlights:

Throughout his career, Mark F McCarty has been associated with renowned companies such as Nutrition 21, Inc. and Ambi Inc. His expertise and dedication to innovation have played a pivotal role in developing groundbreaking solutions for various medical conditions.

Collaborations:

McCarty has collaborated with talented individuals in the field, including Jan Zielinski and John Gustin. Together, they have worked on cutting-edge projects that have the potential to revolutionize healthcare and improve quality of life for many.

Conclusion:

Mark F McCarty's passion for innovation and commitment to advancing healthcare through his patented inventions showcase his invaluable contributions to the industry. His work continues to inspire further advancements in the field, setting a high standard for future inventors to follow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…